Monday, 26 October 2015

Valeant Plans To Dispute Negative Report As Woes Drag Down Pharma Market

Valeant Pharmaceuticals will hold a press conference Monday to "lay out the facts" regarding a report that criticized the company's business practices. Secondary loan prices and stocks for drug and biotechnology companies have also been impacted by the spotlight on Valeant.

No comments:

Post a Comment